Eli Lilly and Co (LLY) shareholder John Chevedden, who has held shares since 2018, has issued a voluntary alert urging fellow shareholders to vote for Proposal 5, which aims to improve shareholder rights. Chevedden highlighted that Eli Lilly recently received a poor shareholder rights score of 9 out of 10, with 10 being the worst. He argued that enhancing shareholder rights could potentially increase the company's market capitalization by $180 million, which would be a significant return on investment if the company were to spend a six-figure sum to promote voting for the proposal. The proposal requires an 80% approval from all shares outstanding. Chevedden also suggested voting against Mr. Jamere Jackson, a member of the Governance Committee, to encourage more shareholder participation and to...Show More

Eli Lilly and Co (LLY) shareholder John Chevedden, who has held shares since 2018, has issued a voluntary alert urging fellow shareholders to vote for Proposal 5, which aims to improve shareholder rights. Chevedden highlighted that Eli Lilly recently received a poor shareholder rights score of 9 out of 10, with 10 being the worst. He argued that enhancing shareholder rights could potentially increase the company's market capitalization by $180 million, which would be a significant return on investment if the company were to spend a six-figure sum to promote voting for the proposal. The proposal requires an 80% approval from all shares outstanding. Chevedden also suggested voting against Mr. Jamere Jackson, a member of the Governance Committee, to encourage more shareholder participation and to push for the Lilly Endowment to vote in favor of the proposal. The endowment holds 10% of LLY stock, and their support could be pivotal in reaching the required approval percentage. Chevedden's submission was made under Rule 14a-6(g)(1) of the Securities Exchange Act of 1934 and was not a solicitation of authority to vote proxies.